| Donors | Values |
| Sex of donors, M/F | 19/18 |
| Median age, years (range) | 34 (13–68) |
| MMSCs | |
| Culture passage at MMSCs harvest | 0–3 |
| Immunophenotype | | CD105 (Endoglin) | 98,6 ± 0,2% | CD73 (SH3, SH4) | 98,1 ± 0,5% | CD90 (Thy-1) | 98 ± 0,5% | CD59 | 98,8 ± 0,1% | Fibroblast Surface Protein (FSP) | 97 ± 0,4% | CD31 (PECAM-1) | 2,5 ± 0,7% | HLA-DR | 3,7 ± 0,7% | CD34 | 0,00% | CD45 | 4,5 ± 0,8% | CD14 | 2,0 ± 0,6% |
| Proportion of viable cells, % | % |
| Median MMSCs cell dose (×106/kg, range) | 1.1 (0.9–1.3) |
| Relative expression level of several genes in MMSCs on passage 2 | | IL-6 | | Ptges | | CSF1 | | IDO1 | | IL-10 | | CFH | |
|
|